» Articles » PMID: 32690710

Redistribution of Metabolic Resources Through Astrocyte Networks Mitigates Neurodegenerative Stress

Overview
Specialty Science
Date 2020 Jul 22
PMID 32690710
Citations 74
Authors
Affiliations
Soon will be listed here.
Abstract

In the central nervous system, glycogen-derived bioenergetic resources in astrocytes help promote tissue survival in response to focal neuronal stress. However, our understanding of the extent to which these resources are mobilized and utilized during neurodegeneration, especially in nearby regions that are not actively degenerating, remains incomplete. Here we modeled neurodegeneration in glaucoma, the world's leading cause of irreversible blindness, and measured how metabolites mobilize through astrocyte gap junctions composed of connexin 43 (Cx43). We elevated intraocular pressure in one eye and determined how astrocyte-derived metabolites in the contralateral optic projection responded. Remarkably, astrocyte networks expand and redistribute metabolites along distances even 10 mm in length, donating resources from the unstressed to the stressed projection in response to intraocular pressure elevation. While resource donation improves axon function and visual acuity in the directly stressed region, it renders the donating tissue susceptible to bioenergetic, structural, and physiological degradation. Intriguingly, when both projections are stressed in a WT animal, axon function and visual acuity equilibrate between the two projections even when each projection is stressed for a different length of time. This equilibration does not occur when Cx43 is not present. Thus, Cx43-mediated astrocyte metabolic networks serve as an endogenous mechanism used to mitigate bioenergetic stress and distribute the impact of neurodegenerative disease processes. Redistribution ultimately renders the donating optic nerve vulnerable to further metabolic stress, which could explain why local neurodegeneration does not remain confined, but eventually impacts healthy regions of the brain more broadly.

Citing Articles

Efficacy of Intravitreal rAAV2-ND4 Injection in Treated Versus Fellow Eyes with Leber's Hereditary Optic Neuropathy: A Meta-Analysis.

Hassan A, Mohsen M, Abu Serhan H Neuroophthalmology. 2024; 48(6):391-400.

PMID: 39583020 PMC: 11581153. DOI: 10.1080/01658107.2024.2360413.


Identification of Sequential Molecular Mechanisms and Key Biomarkers in Early Glaucoma by Integrated Bioinformatics Analysis.

Huang J, Chang Z, Deng X, Cai S, Jiang B, Zeng W Mol Neurobiol. 2024; 62(4):4952-4970.

PMID: 39495230 DOI: 10.1007/s12035-024-04563-0.


Brain Metabolism in Health and Neurodegeneration: The Interplay Among Neurons and Astrocytes.

Shichkova P, Coggan J, Markram H, Keller D Cells. 2024; 13(20.

PMID: 39451233 PMC: 11506225. DOI: 10.3390/cells13201714.


Misprogramming of glucose metabolism impairs recovery of hippocampal slices from neuronal GLT-1 knockout mice and contributes to excitotoxic injury through mitochondrial superoxide production.

Li S, Wang J, Andersen J, Aldana B, Zhang B, Prochownik E J Neurochem. 2024; 169(1):e16205.

PMID: 39193789 PMC: 11659059. DOI: 10.1111/jnc.16205.


Glial metabolic alterations during glaucoma pathogenesis.

Rombaut A, Brautaset R, Williams P, Tribble J Front Ophthalmol (Lausanne). 2024; 3:1290465.

PMID: 38983068 PMC: 11182098. DOI: 10.3389/fopht.2023.1290465.


References
1.
Stokin G, Lillo C, Falzone T, Brusch R, Rockenstein E, Mount S . Axonopathy and transport deficits early in the pathogenesis of Alzheimer's disease. Science. 2005; 307(5713):1282-8. DOI: 10.1126/science.1105681. View

2.
Fei F, Bowdish D, McCarry B . Comprehensive and simultaneous coverage of lipid and polar metabolites for endogenous cellular metabolomics using HILIC-TOF-MS. Anal Bioanal Chem. 2014; 406(15):3723-33. PMC: 4026627. DOI: 10.1007/s00216-014-7797-5. View

3.
Cen L, Han M, Zhou L, Tan L, Liang J, Pang C . Bilateral retinal microglial response to unilateral optic nerve transection in rats. Neuroscience. 2015; 311:56-66. DOI: 10.1016/j.neuroscience.2015.09.067. View

4.
Crish S, Sappington R, Inman D, Horner P, Calkins D . Distal axonopathy with structural persistence in glaucomatous neurodegeneration. Proc Natl Acad Sci U S A. 2010; 107(11):5196-201. PMC: 2841892. DOI: 10.1073/pnas.0913141107. View

5.
Vilchez D, Ros S, Cifuentes D, Pujadas L, Valles J, Garcia-Fojeda B . Mechanism suppressing glycogen synthesis in neurons and its demise in progressive myoclonus epilepsy. Nat Neurosci. 2007; 10(11):1407-13. DOI: 10.1038/nn1998. View